Skip to main content
SpringerLink
Log in

Silicates and Autoimmunity

  • Chapter
Biological Effects of Fibrous and Particulate Substances

  • 538 Accesses

Abstract

Inhalation of particulate matter is associated with a number of acute and chronic disorders including autoimmune rheumatic diseases. The strongest evidence for a link with autoimmune disease comes from epidemiological studies describing the association of occupational exposure to crystalline silica dust with the systemic autoimmune diseases SLE and RA. Very little is known regarding the mechanism by which silica exposure leads to systemic autoimmune disease. However, in the case of silicosis, there is an extensive research literature that can help identify disease processes that may precede development of autoimmunity. The pathophysiology of silicosis consists of deposition of particles into the alveoli of the lung where they cannot be cleared. Ingestion of deposited particles by alveolar macrophages initiates an inflammatory response which then stimulates fibroblasts to proliferate and produce collagen. Silica particles are enveloped by collagen leading to fibrosis and nodular lesions. These findings are consistent with an autoimmune pathogenesis that begins with activation of the innate immune system leading to proinflammatory cytokine production, inflammation of the lung leading to activation of adaptive immunity, breaking of tolerance, autoantibodies, and tissue damage. The variable frequency of these features following silica exposure suggests significant genetic involvement and gene/environment interaction in silica-induced autoimmunity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Grunig G, Marsh LM, Esmaeil N, Jackson K, Gordon T, Reibman J, et al. Perspective: ambient air pollution: inflammatory response and effects on the lung’s vasculature. Pulm Circ. 2014;4(1):25–35.

    Article  PubMed Central  PubMed  Google Scholar 

  2. van Berlo D, Hullmann M, Schins RP. Toxicology of ambient particulate matter. EXS. 2012;101:165–217.

    PubMed  Google Scholar 

  3. Farhat SC, Silva CA, Orione MA, Campos LM, Sallum AM, Braga AL. Air pollution in autoimmune rheumatic diseases: a review. Autoimmun Rev. 2011;11(1):14–21.

    Article  CAS  PubMed  Google Scholar 

  4. Bernatsky S, Fournier M, Pineau CA, Clarke AE, Vinet E, Smargiassi A. Associations between ambient fine particulate levels and disease activity in patients with systemic lupus erythematosus (SLE). Environ Health Perspect. 2011;119(1):45–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Miller FW, Alfredsson L, Costenbader KH, Kamen DL, Nelson LM, Norris JM, et al. Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. J Autoimmun. 2012;39(4):259–71.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Pfau JC, Serve KM, Noonan CW. Autoimmunity and asbestos exposure. Autoimmune Dis. 2014;2014:782045.

    PubMed Central  PubMed  Google Scholar 

  7. Al Aranji G, White D, Solanki K. Scleroderma renal crisis following silicone breast implant rupture: a case report and review of the literature. Clin Exp Rheumatol. 2014;32(2):262–6.

    CAS  PubMed  Google Scholar 

  8. Mossman BT, Glenn RE. Bioreactivity of the crystalline silica polymorphs, quartz and cristobalite, and implications for occupational exposure limits (OELs). Crit Rev Toxicol. 2013;43(8):632–60.

    Article  CAS  PubMed  Google Scholar 

  9. Leung CC, Yu IT, Chen W. Silicosis Lancet. 2012;379(9830):2008–18.

    Article  CAS  PubMed  Google Scholar 

  10. Parks CG, Conrad K, Cooper GS. Occupational exposure to crystalline silica and autoimmune disease. Environ Health Perspect. 1999;107 Suppl 5:793–802.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Castranova V, Vallyathan V. Silicosis and coal workers’ pneumoconiosis. Environ Health Perspect. 2000;108 Suppl 4:675–84.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Pollard KM. Gender differences in autoimmunity associated with exposure to environmental factors. J Autoimmun. 2012;38(2-3):J177–86.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Parks CG, Cooper GS, Nylander-French LA, Sanderson WT, Dement JM, Cohen PL, et al. Occupational exposure to crystalline silica and risk of systemic lupus erythematosus: a population-based, case-control study in the southeastern United States. Arthritis Rheum. 2002;46(7):1840–50.

    Article  PubMed  Google Scholar 

  14. Cooper GS, Wither J, Bernatsky S, Claudio JO, Clarke A, Rioux JD, et al. Occupational and environmental exposures and risk of systemic lupus erythematosus: silica, sunlight, solvents. Rheumatology (Oxford). 2010;49(11):2172–80.

    Article  CAS  Google Scholar 

  15. Khuder SA, Peshimam AZ, Agraharam S. Environmental risk factors for rheumatoid arthritis. Rev Environ Health. 2002;17(4):307–15.

    Article  PubMed  Google Scholar 

  16. Makol A, Reilly MJ, Rosenman KD. Prevalence of connective tissue disease in silicosis (1985–2006)-a report from the state of Michigan surveillance system for silicosis. Am J Ind Med. 2011;54(4):255–62.

    Article  PubMed  Google Scholar 

  17. Conrad K, Mehlhorn J, Luthke K, Dorner T, Frank KH. Systemic lupus erythematosus after heavy exposure to quartz dust in uranium mines: clinical and serological characteristics. Lupus. 1996;5(1):62–9.

    CAS  PubMed  Google Scholar 

  18. Conrad K, Stahnke G, Liedvogel B, Mehlhorn J, Barth J, Blasum C, et al. Anti-CENP-B response in sera of uranium miners exposed to quartz dust and patients with possible development of systemic sclerosis (scleroderma). J Rheumatol. 1995;22(7):1286–94.

    CAS  PubMed  Google Scholar 

  19. Kreiss K, Danilovs JA, Newman LS. Histocompatibility antigens in a population based silicosis series. Br J Ind Med. 1989;46(6):364–9.

    PubMed Central  CAS  PubMed  Google Scholar 

  20. Conrad K, Mehlhorn J. Diagnostic and prognostic relevance of autoantibodies in uranium miners. Int Arch Allergy Immunol. 2000;123(1):77–91.

    Article  CAS  PubMed  Google Scholar 

  21. Doll NJ, Stankus RP, Hughes J, Weill H, Gupta RC, Rodriguez M, et al. Immune complexes and autoantibodies in silicosis. J Allergy Clin Immunol. 1981;68(4):281–5.

    Article  CAS  PubMed  Google Scholar 

  22. Jones RN, Turner-Warwick M, Ziskind M, Weill H. High prevalence of antinuclear antibodies in sandblasters’ silicosis. Am Rev Respir Dis. 1976;113(3):393–5.

    CAS  PubMed  Google Scholar 

  23. Lippmann M, Eckert HL, Hahon N, Morgan WK. Circulating antinuclear and rheumatoid factors in coal miners. A prevalence study in Pennsylvania and West Virginia. Ann Intern Med. 1973;79(6):807–11.

    Article  CAS  PubMed  Google Scholar 

  24. Subra JF, Renier G, Reboul P, Tollis F, Boivinet R, Schwartz P, et al. Lymphopenia in occupational pulmonary silicosis with or without autoimmune disease. Clin Exp Immunol. 2001;126(3):540–4.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Aminian O, Sharifian SA, Mehrdad R, Haghighi KS, Mazaheri M. Antinuclear antibody and rheumatoid factor in silica-exposed workers. Arh Hig Rada Toksikol. 2009;60(2):185–90.

    Article  CAS  PubMed  Google Scholar 

  26. Carlsten C, de Roos AJ, Kaufman JD, Checkoway H, Wener M, Seixas N. Cell markers, cytokines, and immune parameters in cement mason apprentices. Arthritis Rheum. 2007;57(1):147–53.

    Article  CAS  PubMed  Google Scholar 

  27. Sauni R, Oksa P, Lehtimaki L, Toivio P, Palmroos P, Nieminen R, et al. Increased alveolar nitric oxide and systemic inflammation markers in silica-exposed workers. Occup Environ Med. 2012;69(4):256–60.

    Article  CAS  PubMed  Google Scholar 

  28. Huaux F. New developments in the understanding of immunology in silicosis. Curr Opin Allergy Clin Immunol. 2007;7(2):168–73.

    Article  PubMed  Google Scholar 

  29. Steenland K. One agent, many diseases: exposure-response data and comparative risks of different outcomes following silica exposure. Am J Ind Med. 2005;48(1):16–23.

    Article  PubMed  Google Scholar 

  30. Ghahramani N. Silica nephropathy. Int J Occup Environ Med. 2010;1(3):108–15.

    CAS  PubMed  Google Scholar 

  31. Lee S, Hayashi H, Maeda M, Chen Y, Matsuzaki H, Takei-Kumagai N, et al. Environmental factors producing autoimmune dysregulation – chronic activation of T cells caused by silica exposure. Immunobiology. 2012;217(7):743–8.

    Article  CAS  PubMed  Google Scholar 

  32. Otsuki T, Hayashi H, Nishimura Y, Hyodo F, Maeda M, Kumagai N, et al. Dysregulation of autoimmunity caused by silica exposure and alteration of Fas-mediated apoptosis in T lymphocytes derived from silicosis patients. Int J Immunopathol Pharmacol. 2011;24(1 Suppl):11S–6.

    CAS  PubMed  Google Scholar 

  33. Bernstein D, Dunnigan J, Hesterberg T, Brown R, Velasco JA, Barrera R, et al. Health risk of chrysotile revisited. Crit Rev Toxicol. 2013;43(2):154–83.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  34. Liu G, Cheresh P, Kamp DW. Molecular basis of asbestos-induced lung disease. Annu Rev Pathol. 2013;8:161–87.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  35. Noonan CW, Pfau JC, Larson TC, Spence MR. Nested case-control study of autoimmune disease in an asbestos-exposed population. Environ Health Perspect. 2006;114(8):1243–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  36. Olsson AR, Skogh T, Axelson O, Wingren G. Occupations and exposures in the work environment as determinants for rheumatoid arthritis. Occup Environ Med. 2004;61(3):233–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  37. Miller FW, Pollard KM, Parks CG, Germolec DR, Leung PS, Selmi C, et al. Criteria for environmentally associated autoimmune diseases. J Autoimmun. 2012;39(4):253–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  38. Miller FW, Alfredsson L, Costenbader KH, Kamen DL, Nelson LM, Norris JM, et al. Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. J Autoimmun. 2012;39(4):253–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  39. Germolec D, Kono DH, Pfau JC, Pollard KM. Animal models used to examine the role of the environment in the development of autoimmune disease: findings from an NIEHS Expert Panel Workshop. J Autoimmun. 2012;39(4):285–93.

    Article  PubMed Central  PubMed  Google Scholar 

  40. Brown JM, Archer AJ, Pfau JC, Holian A. Silica accelerated systemic autoimmune disease in lupus-prone New Zealand mixed mice. Clin Exp Immunol. 2003;131(3):415–21.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  41. Al-Mogairen SM. Role of sodium silicate in induction of scleroderma-related autoantibodies in brown Norway rats through oral and subcutaneous administration. Rheumatol Int. 2011;31(5):611–5.

    Article  CAS  PubMed  Google Scholar 

  42. Al-Mogairen SM, Al-Arfaj AS, Meo SA, Adam M, Al-Hammad A, Gad El Rab MO. Induction of autoimmunity in Brown Norway rats by oral and parenteral administration of sodium silicate. Lupus. 2009;18(5):413–7.

    Article  CAS  PubMed  Google Scholar 

  43. Brown JM, Pfau JC, Holian A. Immunoglobulin and lymphocyte responses following silica exposure in New Zealand mixed mice. Inhal Toxicol. 2004;16(3):133–9.

    Article  CAS  PubMed  Google Scholar 

  44. Hala K, Malin G, Dietrich H, Loesch U, Boeck G, Wolf H, et al. Analysis of the initiation period of spontaneous autoimmune thyroiditis (SAT) in obese strain (OS) of chickens. J Autoimmun. 1996;9(2):129–38.

    Article  CAS  PubMed  Google Scholar 

  45. Nash JR, Everson NW, Wood RF, Bell PR. Effect of silica and carrageenan on the survival of islet allografts. Transplantation. 1980;29(3):206–8.

    Article  CAS  PubMed  Google Scholar 

  46. Wright Jr JR, Lacy PE. Silica prevents the induction of diabetes with complete Freund’s adjuvant and low-dose streptozotocin in rats. Diabetes Res. 1989;11(2):51–4.

    PubMed  Google Scholar 

  47. Amano K, Yoon JW. Studies on autoimmunity for initiation of beta-cell destruction. V. Decrease of macrophage-dependent T lymphocytes and natural killer cytotoxicity in silica-treated BB rats. Diabetes. 1990;39(5):590–6.

    Article  CAS  PubMed  Google Scholar 

  48. Pfau JC, Sentissi JJ, Li S, Calderon-Garciduenas L, Brown JM, Blake DJ. Asbestos-induced autoimmunity in C57BL/6 mice. J Immunotoxicol. 2008;5(2):129–37.

    Article  CAS  PubMed  Google Scholar 

  49. Ferro A, Zebedeo CN, Davis C, Ng KW, Pfau JC. Amphibole, but not chrysotile, asbestos induces anti-nuclear autoantibodies and IL-17 in C57BL/6 mice. J Immunotoxicol. 2014;11(3):283–90.

    Article  CAS  PubMed  Google Scholar 

  50. Zebedeo CN, Davis C, Pena C, Ng KW, Pfau JC. Erionite induces production of autoantibodies and IL-17 in C57BL/6 mice. Toxicol Appl Pharmacol. 2014;275(3):257–64.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  51. Salazar KD, Copeland CB, Luebke RW. Effects of Libby amphibole asbestos exposure on two models of arthritis in the Lewis rat. J Toxicol Environ Health A. 2012;75(6):351–65.

    Article  CAS  PubMed  Google Scholar 

  52. Salazar KD, Copeland CB, Wood CE, Schmid JE, Luebke RW. Evaluation of anti-nuclear antibodies and kidney pathology in Lewis rats following exposure to Libby amphibole asbestos. J Immunotoxicol. 2013;10(4):329–33.

    Article  CAS  PubMed  Google Scholar 

  53. Mahler M, Miller FW, Fritzler MJ. Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review. Autoimmun Rev. 2014;13(4-5):367–71.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  54. Lee S, Matsuzaki H, Kumagai-Takei N, Yoshitome K, Maeda M, Chen Y, et al. Silica exposure and altered regulation of autoimmunity. Environ Health Prev Med. 2014;19(5):322–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  55. Tomokuni A, Otsuki T, Isozaki Y, Kita S, Ueki H, Kusaka M, et al. Serum levels of soluble Fas ligand in patients with silicosis. Clin Exp Immunol. 1999;118(3):441–4.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  56. Ueki A, Isozaki Y, Tomokuni A, Ueki H, Kusaka M, Tanaka S, et al. Different distribution of HLA class II alleles in anti-topoisomerase I autoantibody responders between silicosis and systemic sclerosis patients, with a common distinct amino acid sequence in the HLA-DQB1 domain. Immunobiology. 2001;204(4):458–65.

    Article  CAS  PubMed  Google Scholar 

  57. Otsuki T, Sakaguchi H, Tomokuni A, Aikoh T, Matsuki T, Kawakami Y, et al. Soluble Fas mRNA is dominantly expressed in cases with silicosis. Immunology. 1998;94(2):258–62.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  58. Silman AJ, Pearson JE. Epidemiology and genetics of rheumatoid arthritis. Arthritis Res. 2002;4 Suppl 3:S265–72.

    Article  PubMed Central  PubMed  Google Scholar 

  59. Osio-Salido E, Manapat-Reyes H. Epidemiology of systemic lupus erythematosus in Asia. Lupus. 2010;19(12):1365–73.

    Article  CAS  PubMed  Google Scholar 

  60. Tomokuni A, Otsuki T, Sakaguchi H, Isozaki Y, Hyodoh F, Kusaka M, et al. Detection of anti-topoisomerase I autoantibody in patients with silicosis. Environ Health Prev Med. 2002;7(1):7–10.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  61. Basu D, Reveille JD. Anti-scl-70. Autoimmunity. 2005;38(1):65–72.

    Article  CAS  PubMed  Google Scholar 

  62. Takata-Tomokuni A, Ueki A, Shiwa M, Isozaki Y, Hatayama T, Katsuyama H, et al. Detection, epitope-mapping and function of anti-Fas autoantibody in patients with silicosis. Immunology. 2005;116(1):21–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  63. Ueki A, Isozaki Y, Tomokuni A, Hatayama T, Ueki H, Kusaka M, et al. Intramolecular epitope spreading among anti-caspase-8 autoantibodies in patients with silicosis, systemic sclerosis and systemic lupus erythematosus, as well as in healthy individuals. Clin Exp Immunol. 2002;129(3):556–61.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  64. Ueki H, Kohda M, Nobutoh T, Yamaguchi M, Omori K, Miyashita Y, et al. Antidesmoglein autoantibodies in silicosis patients with no bullous diseases. Dermatology. 2001;202(1):16–21.

    Article  CAS  PubMed  Google Scholar 

  65. Parks CG, Miller FW, Pollard KM, Selmi C, Germolec D, Joyce K, et al. Expert panel workshop consensus statement on the role of the environment in the development of autoimmune disease. Int J Mol Sci. 2014;15(8):14269–97.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  66. Davis GS, Leslie KO, Hemenway DR. Silicosis in mice: effects of dose, time, and genetic strain. J Environ Pathol Toxicol Oncol. 1998;17(2):81–97.

    CAS  PubMed  Google Scholar 

  67. Callis AH, Sohnle PG, Mandel GS, Wiessner J, Mandel NS. Kinetics of inflammatory and fibrotic pulmonary changes in a murine model of silicosis. J Lab Clin Med. 1985;105(5):547–53.

    CAS  PubMed  Google Scholar 

  68. Ohtsuka Y, Wang XT, Saito J, Ishida T, Munakata M. Genetic linkage analysis of pulmonary fibrotic response to silica in mice. Eur Respir J. 2006;28(5):1013–9.

    Article  CAS  PubMed  Google Scholar 

  69. Rabolli V, Lo Re S, Uwambayinema F, Yakoub Y, Lison D, Huaux F. Lung fibrosis induced by crystalline silica particles is uncoupled from lung inflammation in NMRI mice. Toxicol Lett. 2011;203(2):127–34.

    Article  CAS  PubMed  Google Scholar 

  70. Foo SY, Phipps S. Regulation of inducible BALT formation and contribution to immunity and pathology. Mucosal Immunol. 2010;3(6):537–44.

    Article  CAS  PubMed  Google Scholar 

  71. Miller FW, Pollard KM, Parks CG, Germolec DR, Leung PS, Selmi C, et al. Criteria for environmentally associated autoimmune diseases. J Autoimmun. 2012;39(4):253–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  72. Giordano G, van den Brule S, Lo Re S, Triqueneaux P, Uwambayinema F, Yakoub Y, et al. Type I interferon signaling contributes to chronic inflammation in a murine model of silicosis. Toxicol Sci. 2010;116(2):682–92.

    Article  CAS  PubMed  Google Scholar 

  73. Barbarin V, Nihoul A, Misson P, Arras M, Delos M, Leclercq I, et al. The role of pro- and anti-inflammatory responses in silica-induced lung fibrosis. Respir Res. 2005;6:112.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  74. Guo J, Gu N, Chen J, Shi T, Zhou Y, Rong Y, et al. Neutralization of interleukin-1 beta attenuates silica-induced lung inflammation and fibrosis in C57BL/6 mice. Arch Toxicol. 2013;87(11):1963–73.

    Article  CAS  PubMed  Google Scholar 

  75. Choi M, Cho WS, Han BS, Cho M, Kim SY, Yi JY, et al. Transient pulmonary fibrogenic effect induced by intratracheal instillation of ultrafine amorphous silica in A/J mice. Toxicol Lett. 2008;182(1-3):97–101.

    Article  CAS  PubMed  Google Scholar 

  76. Beamer CA, Holian A. Antigen-presenting cell population dynamics during murine silicosis. Am J Respir Cell Mol Biol. 2007;37(6):729–38.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  77. Davis GS, Pfeiffer LM, Hemenway DR. Interferon-gamma production by specific lung lymphocyte phenotypes in silicosis in mice. Am J Respir Cell Mol Biol. 2000;22(4):491–501.

    Article  CAS  PubMed  Google Scholar 

  78. Lo Re S, Dumoutier L, Couillin I, Van Vyve C, Yakoub Y, Uwambayinema F, et al. IL-17A-producing gammadelta T and Th17 lymphocytes mediate lung inflammation but not fibrosis in experimental silicosis. J Immunol. 2010;184(11):6367–77.

    Article  CAS  PubMed  Google Scholar 

  79. Misson P, Brombacher F, Delos M, Lison D, Huaux F. Type 2 immune response associated with silicosis is not instrumental in the development of the disease. Am J Physiol Lung Cell Mol Physiol. 2007;292(1):L107–13.

    Article  CAS  PubMed  Google Scholar 

  80. Maeda M, Nishimura Y, Kumagai N, Hayashi H, Hatayama T, Katoh M, et al. Dysregulation of the immune system caused by silica and asbestos. J Immunotoxicol. 2010;7(4):268–78.

    Article  CAS  PubMed  Google Scholar 

  81. Beamer CA, Migliaccio CT, Jessop F, Trapkus M, Yuan D, Holian A. Innate immune processes are sufficient for driving silicosis in mice. J Leukoc Biol. 2010;88(3):547–57.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  82. Hamilton Jr RF, Thakur SA, Mayfair JK, Holian A. MARCO mediates silica uptake and toxicity in alveolar macrophages from C57BL/6 mice. J Biol Chem. 2006;281(45):34218–26.

    Article  CAS  PubMed  Google Scholar 

  83. Rabolli V, Badissi A, Devosse R, Uwambayinema F, Yakoub Y, Palmai-Pallag M, et al. The alarmin IL-1α is a master cytokine in acute lung inflammation induced by silica micro- and nanoparticles. Part Fibre Toxicol. 2014;11(1):69.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  84. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol. 2008;9(8):847–56.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  85. Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science. 2008;320(5876):674–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  86. Kusaka T, Nakayama M, Nakamura K, Ishimiya M, Furusawa E, Ogasawara K. Effect of silica particle size on macrophage inflammatory responses. PLoS One. 2014;9(3), e92634.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  87. Harijith A, Ebenezer DL, Natarajan V. Reactive oxygen species at the crossroads of inflammasome and inflammation. Front Physiol. 2014;5:352.

    Article  PubMed Central  PubMed  Google Scholar 

  88. Hari A, Zhang Y, Tu Z, Detampel P, Stenner M, Ganguly A, et al. Activation of NLRP3 inflammasome by crystalline structures via cell surface contact. Sci Rep. 2014;4:7281.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  89. Li M, Gunter ME, Fukagawa NK. Differential activation of the inflammasome in THP-1 cells exposed to chrysotile asbestos and Libby “six-mix” amphiboles and subsequent activation of BEAS-2B cells. Cytokine. 2012;60(3):718–30.

    Article  CAS  PubMed  Google Scholar 

  90. Davis GS, Pfeiffer LM, Hemenway DR. Persistent overexpression of interleukin-1beta and tumor necrosis factor-alpha in murine silicosis. J Environ Pathol Toxicol Oncol. 1998;17(2):99–114.

    CAS  PubMed  Google Scholar 

  91. Hubbard AK, Timblin CR, Shukla A, Rincon M, Mossman BT. Activation of NF-kappaB-dependent gene expression by silica in lungs of luciferase reporter mice. Am J Physiol Lung Cell Mol Physiol. 2002;282(5):L968–75.

    Article  CAS  PubMed  Google Scholar 

  92. Ohtsuka Y, Munakata M, Ukita H, Takahashi T, Satoh A, Homma Y, et al. Increased susceptibility to silicosis and TNF-alpha production in C57BL/6J mice. Am J Respir Crit Care Med. 1995;152(6 Pt 1):2144–9.

    Article  CAS  PubMed  Google Scholar 

  93. Davis GS, Holmes CE, Pfeiffer LM, Hemenway DR. Lymphocytes, lymphokines, and silicosis. J Environ Pathol Toxicol Oncol. 2001;20 Suppl 1:53–65.

    CAS  PubMed  Google Scholar 

  94. Piguet PF, Collart MA, Grau GE, Sappino AP, Vassalli P. Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature. 1990;344(6263):245–7.

    Article  CAS  PubMed  Google Scholar 

  95. Kumar RK. Quantitative immunohistologic assessment of lymphocyte populations in the pulmonary inflammatory response to intratracheal silica. Am J Pathol. 1989;135(4):605–14.

    PubMed Central  CAS  PubMed  Google Scholar 

  96. Arras M, Huaux F, Vink A, Delos M, Coutelier JP, Many MC, et al. Interleukin-9 reduces lung fibrosis and type 2 immune polarization induced by silica particles in a murine model. Am J Respir Cell Mol Biol. 2001;24(4):368–75.

    Article  CAS  PubMed  Google Scholar 

  97. Barbarin V, Arras M, Misson P, Delos M, McGarry B, Phan SH, et al. Characterization of the effect of interleukin-10 on silica-induced lung fibrosis in mice. Am J Respir Cell Mol Biol. 2004;31(1):78–85.

    Article  CAS  PubMed  Google Scholar 

  98. Lo Re S, Lison D, Huaux F. CD4+ T lymphocytes in lung fibrosis: diverse subsets, diverse functions. J Leukoc Biol. 2013;93(4):499–510.

    Article  CAS  PubMed  Google Scholar 

  99. Wu P, Miura Y, Hyodoh F, Nishimura Y, Hatayama T, Hatada S, et al. Reduced function of CD4+25+ regulatory T cell fraction in silicosis patients. Int J Immunopathol Pharmacol. 2006;19(2):357–68.

    CAS  PubMed  Google Scholar 

  100. Hayashi H, Miura Y, Maeda M, Murakami S, Kumagai N, Nishimura Y, et al. Reductive alteration of the regulatory function of the CD4(+)CD25(+) T cell fraction in silicosis patients. Int J Immunopathol Pharmacol. 2010;23(4):1099–109.

    CAS  PubMed  Google Scholar 

  101. Hayashi H, Maeda M, Murakami S, Kumagai N, Chen Y, Hatayama T, et al. Soluble interleukin-2 receptor as an indicator of immunological disturbance found in silicosis patients. Int J Immunopathol Pharmacol. 2009;22(1):53–62.

    CAS  PubMed  Google Scholar 

  102. Russell SE, Moore AC, Fallon PG, Walsh PT. Soluble IL-2Ralpha (sCD25) exacerbates autoimmunity and enhances the development of Th17 responses in mice. PLoS One. 2012;7(10), e47748.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  103. Weissman DN, Hubbs AF, Huang SH, Stanley CF, Rojanasakul Y, Ma JK. IgG subclass responses in experimental silicosis. J Environ Pathol Toxicol Oncol. 2001;20 Suppl 1:67–74.

    CAS  PubMed  Google Scholar 

  104. Huang SH, Hubbs AF, Stanley CF, Vallyathan V, Schnabel PC, Rojanasakul Y, et al. Immunoglobulin responses to experimental silicosis. Toxicol Sci. 2001;59(1):108–17.

    Article  CAS  PubMed  Google Scholar 

  105. Kalliny MS, Bassyouni MI. Immune response due to silica exposure in Egyptian phosphate mines. J Health Care Poor Underserved. 2011;22(4 Suppl):91–109.

    Article  PubMed  Google Scholar 

  106. Calhoun WJ, Christman JW, Ershler WB, Graham WG, Davis GS. Raised immunoglobulin concentrations in bronchoalveolar lavage fluid of healthy granite workers. Thorax. 1986;41(4):266–73.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  107. Karnik AB, Saiyed HN, Nigam SK. Humoral immunologic dysfunction in silicosis. Indian J Med Res. 1990;92:440–2.

    CAS  PubMed  Google Scholar 

  108. Mahler M, Bluthner M, Pollard KM. Advances in B-cell epitope analysis of autoantigens in connective tissue diseases. Clin Immunol. 2003;107(2):65–79.

    Article  CAS  PubMed  Google Scholar 

  109. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003;349(16):1526–33.

    Article  CAS  PubMed  Google Scholar 

  110. Davis GS, Pfeiffer LM, Hemenway DR, Rincon M. Interleukin-12 is not essential for silicosis in mice. Part Fibre Toxicol. 2006;3:2.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  111. Cassel SL, Eisenbarth SC, Iyer SS, Sadler JJ, Colegio OR, Tephly LA, et al. The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci U S A. 2008;105(26):9035–40.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  112. Biswas R, Bunderson-Schelvan M, Holian A. Potential role of the inflammasome-derived inflammatory cytokines in pulmonary fibrosis. Pulm Med. 2011;2011:105707.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  113. Srivastava KD, Rom WN, Jagirdar J, Yie TA, Gordon T, Tchou-Wong KM. Crucial role of interleukin-1beta and nitric oxide synthase in silica-induced inflammation and apoptosis in mice. Am J Respir Crit Care Med. 2002;165(4):527–33.

    Article  PubMed  Google Scholar 

  114. Re SL, Yakoub Y, Devosse R, Uwambayinema F, Couillin I, Ryffel B, et al. Uncoupling between inflammatory and fibrotic responses to silica: evidence from MyD88 knockout mice. PLoS One. 2014;9(7), e99383.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  115. Thakur SA, Beamer CA, Migliaccio CT, Holian A. Critical role of MARCO in crystalline silica-induced pulmonary inflammation. Toxicol Sci. 2009;108(2):462–71.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  116. Beamer CA, Holian A. Scavenger receptor class A type I/II (CD204) null mice fail to develop fibrosis following silica exposure. Am J Physiol Lung Cell Mol Physiol. 2005;289(2):L186–95.

    Article  CAS  PubMed  Google Scholar 

  117. Wermeling F, Chen Y, Pikkarainen T, Scheynius A, Winqvist O, Izui S, et al. Class A scavenger receptors regulate tolerance against apoptotic cells, and autoantibodies against these receptors are predictive of systemic lupus. J Exp Med. 2007;204(10):2259–65.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  118. Churchill GA, Gatti DM, Munger SC, Svenson KL. The diversity outbred mouse population. Mamm Genome. 2012;23(9–10):713–8.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular and Experimental Medicine, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA, USA

    Jessica M. Mayeux, Rahul D. Pawar & K. Michael Pollard

Authors
  1. Jessica M. Mayeux
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rahul D. Pawar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Michael Pollard
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. Michael Pollard .

Editor information

Editors and Affiliations

  1. Dept. Hygiene, Kawasaki Medical School, Kurashiki, Okayama, Japan

    Takemi Otsuki

  2. Dept. of Toxicology and Safety Science Osaka University, Suita, Osaka, Japan

    Yasuo Yoshioka

  3. Center for Env. Health Sciences University of Montana, Missoula, Minnesota, USA

    Andrij Holian

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Japan

About this chapter

Cite this chapter

Mayeux, J.M., Pawar, R.D., Pollard, K.M. (2016). Silicates and Autoimmunity. In: Otsuki, T., Yoshioka, Y., Holian, A. (eds) Biological Effects of Fibrous and Particulate Substances. Current Topics in Environmental Health and Preventive Medicine. Springer, Tokyo. https://doi.org/10.1007/978-4-431-55732-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-55732-6_9

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-55731-9

  • Online ISBN: 978-4-431-55732-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation